Please use this identifier to cite or link to this item:
Title: Understanding zika virus stability and developing a chimeric vaccine through functional analysis
Authors: Xie, X
Yang, Y
Muruato, A.E
Zou, J
Shan, C
Nunes, B.T.D
Medeiros, D.B.A
Vasconcelos, P.F.C
Weaver, S.C
Rossi, S.L
Shi, P.-Y 
Keywords: neutralizing antibody
live vaccine
prM protein, Flavivirus
virus envelope protein
virus vaccine
animal experiment
animal model
antibody response
cohort analysis
controlled study
Dengue virus 2
hydrogen bond
limit of detection
limit of quantitation
prM E gene
virus gene
virus morphology
virus pathogenesis
Zika fever
Zika virus
amino acid substitution
Dengue virus
disease model
dna mutational analysis
gene deletion
genetic recombination
isolation and purification
radiation response
virus replication
Zika Virus Infection
Amino Acid Substitution
Dengue Virus
Disease Models, Animal
DNA Mutational Analysis
Recombination, Genetic
Sequence Deletion
Vaccines, Attenuated
Viral Envelope Proteins
Viral Vaccines
Virus Replication
Zika Virus
Zika Virus Infection
Issue Date: 2017
Publisher: American Society for Microbiology
Citation: Xie, X, Yang, Y, Muruato, A.E, Zou, J, Shan, C, Nunes, B.T.D, Medeiros, D.B.A, Vasconcelos, P.F.C, Weaver, S.C, Rossi, S.L, Shi, P.-Y (2017). Understanding zika virus stability and developing a chimeric vaccine through functional analysis. mBio 8 (1) : e02134-16. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: Compared with other flaviviruses, Zika virus (ZIKV) is uniquely associated with congenital diseases in pregnant women. One recent study reported that (i) ZIKV has higher thermostability than dengue virus (DENV [a flavivirus closely related to ZIKV]), which might contribute to the disease outcome; (ii) the higher thermostability of ZIKV could arise from an extended loop structure in domain III of the viral envelope (E) protein and an extra hydrogen-bond interaction between E molecules (V. A. Kostyuchenko, E. X. Y. Lim, S. Zhang, G. Fibriansah, T.-S. Ng, J. S. G. Ooi, J. Shi, and S.-M. Lok, Nature 533:425–428, 2016, Here we report the functional analysis of the structural information in the context of complete ZIKV and DENV-2 virions. Swapping the prM-E genes between ZIKV and DENV-2 switched the thermostability of the chimeric viruses, identifying the prM-E proteins as the major determinants for virion thermostability. Shortening the extended loop of the E protein by 1 amino acid was lethal for ZIKV assembly/release. Mutations (Q350I and T351V) that abolished the extra hydrogen-bond interaction between the E proteins did not reduce ZIKV thermostability, indicating that the extra interaction does not increase the thermostability. Interestingly, mutant T351V was attenuated in A129 mice defective in type I interferon receptors, even though the virus retained the wild-type thermostability. Furthermore, we found that a chimeric ZIKV with the DENV-2 prM-E and a chimeric DENV-2 with the ZIKV prM-E were highly attenuated in A129 mice; these chimeric viruses were highly immunogenic and protective against DENV-2 and ZIKV challenge, respectively. These results indicate the potential of these chimeric viruses for vaccine development.IMPORTANCE Analysis of a recently observed high-resolution structure of ZIKV led to a hypothesis that its unusual stability may contribute to the associated, unique disease outcomes. Here we performed a functional analysis to demonstrate that viral prM-E genes are the main determinants for the high stability of ZIKV. The extra hydrogen-bond interaction (observed in the high-resolution structure) between ZIKV E proteins did not enhance virion stability, whereas the extended loop of E protein (CD loop in domain III) was essential for ZIKV assembly. More importantly, we found that a chimeric ZIKV with DENV-2 prM-E genes and a chimeric DENV-2 with ZIKV prM-E genes were highly attenuated in A129 mice. Mice immunized with these chimeric viruses generated robust neutralizing antibody responses and were fully protected from DENV-2 and ZIKV challenge, respectively, indicating that these chimeric viruses could be further developed as vaccine candidates. © 2017 Xie et al.
Source Title: mBio
ISSN: 2161-2129
DOI: 10.1128/mBio.02134-16
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1128_mBio_02134-16.pdf5.49 MBAdobe PDF



Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons